"A+H pharmaceutical industry leader" debuts on the Hong Kong stock market! Hengrui Pharma opened high on the first day, rising over 35%

Hengrui Pharma (01276.HK) opened high on its first day, rising 36.66% as of the time of publication, trading at HKD 60.2.

According to previous reports, Hengrui Pharma received a subscription rate of 454.85 times during the public offering phase. After reallocation, the final number of shares offered in the public offering was 48.2718 million shares, accounting for approximately 21.5% of the total shares offered. A total of 203,900 valid applications were received, with 92,400 applications accepted, and the percentage of shares allocated for each lot applied for was approximately 10%. In addition, during the international placement phase, Hengrui Pharma received a subscription rate of 17.09 times. After reallocation, the final number of shares offered in the international placement was 176 million shares, equivalent to 78.5% of the total shares offered